Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214


Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.

Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW.

Int J Tuberc Lung Dis. 2013 Apr;17(4):552-8. doi: 10.5588/ijtld.12.0627.


Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.

Lawn SD, Kerkhoff AD, Burton R, Schutz C, Boulle A, Vogt M, Gupta-Wright A, Nicol MP, Meintjes G.

BMC Med. 2017 Mar 21;15(1):67. doi: 10.1186/s12916-017-0822-8.


Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.

Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE.

AIDS. 2013 Nov 28;27(18):2883-92. doi: 10.1097/QAD.0000000000000008.


Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2014 Jan;2(1):e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.


Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.

Azadi M, Bishai DM, Dowdy DW, Moulton LH, Cavalcante S, Saraceni V, Pacheco AG, Cohn S, Chaisson RE, Durovni B, Golub JE.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1443-8. doi: 10.5588/ijtld.14.0108.


Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.

Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BA, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):270-9. doi: 10.1097/QAI.0000000000000151.


The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.

Thit SS, Aung NM, Htet ZW, Boyd MA, Saw HA, Anstey NM, Kyi TT, Cooper DA, Kyi MM, Hanson J.

BMC Med. 2017 Aug 4;15(1):145. doi: 10.1186/s12916-017-0888-3.


Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.

d'Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E.

Pan Afr Med J. 2015 Sep 3;22:4. doi: 10.11604/pamj.2015.22.4.6075. eCollection 2015.


Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.

Dowdy DW, O'Brien MA, Bishai D.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1021-9.


Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.

Dowdy DW, Steingart KR, Pai M.

PLoS Med. 2011 Aug;8(8):e1001074. doi: 10.1371/journal.pmed.1001074. Epub 2011 Aug 9.


Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.

Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen L, Mabey D, Mills A, Hayes R.

Lancet. 1997 Dec 20-27;350(9094):1805-9.


Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.

Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, Mehta N, Calligaro G, Lombard CJ, Kadzirange G, Bandason T, Chansa A, Liusha N, Mangu C, Mtafya B, Msila H, Rachow A, Hoelscher M, Mwaba P, Theron G, Dheda K.

Lancet. 2016 Mar 19;387(10024):1187-97. doi: 10.1016/S0140-6736(15)01092-2. Epub 2016 Mar 10.


Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.

BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4.


Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.

Lawn SD, Kerkhoff AD, Vogt M, Wood R.

AIDS. 2012 Aug 24;26(13):1635-43. doi: 10.1097/QAD.0b013e3283553685.


Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.

Kerkhoff AD, Wood R, Vogt M, Lawn SD.

PLoS One. 2014 Jul 30;9(7):e103285. doi: 10.1371/journal.pone.0103285. eCollection 2014.


Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.

Drain PK, Gounder L, Grobler A, Sahid F, Bassett IV, Moosa MY.

BMJ Open. 2015 Apr 15;5(4):e006833. doi: 10.1136/bmjopen-2014-006833.


Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.


The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG.

PLoS One. 2015 Dec 30;10(12):e0145796. doi: 10.1371/journal.pone.0145796. eCollection 2015.

Supplemental Content

Support Center